Correction: Isatin-based benzyloxybenzene derivatives as monoamine oxidase inhibitors with neuroprotective effect targeting neurodegenerative disease treatment

Feba Benny; Jong Min Oh; Sunil Kumar; Mohamed A. Abdelgawad; Mohammed M. Ghoneim; Mohamed Sadek Abdel-Bakky; Neelima Kukerti; Jobin Jose; Hoon Kim; Bijo Mathew

doi:10.1039/D3RA90123H

Correction: Isatin-based benzyloxybenzene derivatives as monoamine oxidase inhibitors with neuroprotective effect targeting neurodegenerative disease treatment

Feba Benny,^a Jong Min Oh,^b Sunil Kumar,^a Mohamed A. Abdelgawad,^c Mohammed M. Ghoneim,^d Mohamed Sadek Abdel-Bakky,^e Neelima Kukerti,^f Jobin Jose,^g Hoon Kim*^b and Bijo Mathew*^a

Author affiliations

* Corresponding authors

^a Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi 682041, India
E-mail: febacbenny@gmail.com, solankimedchem@gmail.com, bijovilaventgu@gmail.com, bijomathew@aims.amrita.edu

^b Department of Pharmacy, Research Institute of Life Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Republic of Korea
E-mail: ddazzo005@naver.com, hoon@sunchon.ac.kr

^c Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia
E-mail: mhmdgwd@ju.edu.sa

^d Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Ad Diriyah 13713, Saudi Arabia
E-mail: mghoneim@mcst.edu.sa

^e Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia
E-mail: abdelbakkym@yahoo.com

^f School of Pharmacy, Graphic Era Hill University, Dehradun, Uttarakhand 248002, India
E-mail: nkukreti@gehu.ac.in

^g Department of Pharmaceutics, NGSM Institute of Pharmaceutical Science, NITTE University, Mangalore, Karnataka 575018, India
E-mail: jjmattam07@gmail.com

Abstract

Correction for ‘Isatin-based benzyloxybenzene derivatives as monoamine oxidase inhibitors with neuroprotective effect targeting neurodegenerative disease treatment’ by Feba Benny et al., RSC Adv., 2023, 13, 35240–35250, https://doi.org/10.1039/D3RA07035B.

RSC Advances

Correction: Isatin-based benzyloxybenzene derivatives as monoamine oxidase inhibitors with neuroprotective effect targeting neurodegenerative disease treatment

Abstract

Associated articles

Article information

Download Citation

Permissions

Correction: Isatin-based benzyloxybenzene derivatives as monoamine oxidase inhibitors with neuroprotective effect targeting neurodegenerative disease treatment

Social activity

Search articles by author

Spotlight

Advertisements